Skip to main navigation Skip to search Skip to main content

Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt

  • Subhojit Dey
  • , Amr S. Soliman
  • , Ahmad Hablas
  • , Ibrahim A. Seifeldin
  • , Kadry Ismail
  • , Mohamed Ramadan
  • , Hesham El-Hamzawy
  • , Mark L. Wilson
  • , Mousumi Banerjee
  • , Paolo Boffetta
  • , Joe Harford
  • , Sofia D. Merajver
  • University of Michigan, Ann Arbor
  • Gharbiah Cancer Society
  • Tanta Cancer Center
  • National Institutes of Health

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Abstract

Breast cancer incidence is higher in developed countries with higher rates of estrogen receptor positive (ER+) tumors. ER+ tumors are caused by estrogenic exposures although known exposures explain approximately 50% of breast cancer risk. Unknown risk factors causing high breast cancer incidence exist that are estrogenic and development-related. Xenoestrogens are such risk factors but are difficult to study since developed countries lack unexposed populations. Developing countries have urban-rural populations with differential exposure to xenoestrogens. This study assessed urban-rural breast cancer incidence classified by hormone receptor status using data from Gharbiah population-based cancer registry in Egypt from 2001 to 2006. Urban ER+ incidence rate (per 100,000 women) was 2-4 times (IRR = 3.36, 95% CI = 4.84, 2.34) higher than rural incidence rate. ER-incidence rate was 2-3 times (IRR = 1.86, 95% CI = 2.38, 1.45) higher in urban areas than in rural areas. Our findings indicate that urban women may probably have a higher exposure to xenoestrogens.

Original languageEnglish
Pages (from-to)149-160
Number of pages12
JournalBreast Cancer Research and Treatment
Volume120
Issue number1
DOIs
StatePublished - Feb 2010

Keywords

  • Breast cancer incidence
  • Egypt
  • Hormone receptor status
  • Mammary stem cells
  • Xenoestrogens

Fingerprint

Dive into the research topics of 'Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt'. Together they form a unique fingerprint.

Cite this